DEA Seeks Public Input on SpecGx LLC Controlled Substance Import Application
March 26, 2025
March 26, 2025
WASHINGTON, March 26 (TNSFR) -- The U.S. Department of Justice Drug Enforcement Administration (DEA) has announced that SpecGx LLC, a pharmaceutical company based in Saint Louis, Missouri, has applied for registration as an importer of controlled substances.
The company is seeking authorization to import multiple Schedule II controlled substances, including phenylacetone, coca leaves, thebaine, raw opium, poppy straw concentrate, and tapentadol. This request, published in the Fede . . .
The company is seeking authorization to import multiple Schedule II controlled substances, including phenylacetone, coca leaves, thebaine, raw opium, poppy straw concentrate, and tapentadol. This request, published in the Fede . . .